Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-24-021581)

Filing Details

Accession Number:: 0001127602-24-021581
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-05 16:04:42
Reporting Period:: 2024-08-01

Accepted Time:: 2024-08-05 16:04:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100682	Charles River Laboratories International Inc.	CRL	Services-Commercial Physical & Biological Research (8731)	061397316

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1141722	C James Foster	C/O Charles River Laboratories 251 Ballardvale Street Wilmington MA 01887	Chairman, President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-08-01	25,000	$250.00	188,251	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,580	Indirect	2022 GRAT
Common Stock	9,793	Indirect	2023 GRAT
Common Stock	20,000	Indirect	2024 GRAT
Common Stock	230	Indirect	by Trust
Common Stock	750	Indirect	By Trust
Common Stock	2,250	Indirect	By Trust
Common Stock	10,000	Indirect	Held By Spouse

Footnotes

This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 26, 2024.
On 6/5/2024, 10,207 shares were transferred from the 2023 GRAT account to Direct holdings.
On 6/6/2024, 20,000 shares were transferred from Direct holdings to 2024 GRAT account.
Reflects a reduction by 110 shares that were inadvertently reported as being held by the Reporting Person.